23 August 2021 - ATAGI met on Wednesday 18 August 2021 to review the latest developments relating to COVID-19 and COVID-19 vaccine safety.
ATAGI considered an update from the Therapeutic Goods Administration on current confirmed cases of thrombosis and thrombocytopenia syndrome and those under investigation.